Individual circumstances should guide this decision
A Phase I safety study and a Phase II ulcerative colitis trial of the BPC-157 formulation PL 14736 were conducted by the Croatian pharmaceutical company Pliva, but full peer-reviewed Phase II efficacy results have not been published
Disclaimer: While early studies suggest promising effects on gut health, more research is needed
I ordered this to help me jump start my weight loss journey
Once it is maxed out, anything left over has to rely on the second pathway, passive diffusion, where B12 simply seeps across the intestinal wall on its own
Practically, any before & after changes attributed to MIC/B12 should be viewed as adjunctive to fundamentalscalorie deficit, adequate protein, resistance training, daily steps, and sleeprather than a guaranteed pharmacologic effect